Total Payments
$15,308
2022 Payments
$433.55
Companies
15
Transactions
78
Medicare Patients
93
Medicare Billing
$8,947
Payment Breakdown by Category
Consulting$9,418 (61.5%)
Travel$3,083 (20.1%)
Food & Beverage$2,397 (15.7%)
Education$409.92 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,418 | 4 | 61.5% |
| Travel and Lodging | $3,083 | 11 | 20.1% |
| Food and Beverage | $2,397 | 56 | 15.7% |
| Education | $409.92 | 7 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $8,302 | 36 | $0 (2019) |
| AbbVie, Inc. | $5,613 | 13 | $0 (2019) |
| Merck Sharp & Dohme LLC | $379.43 | 3 | $0 (2022) |
| Astellas Pharma US Inc | $307.98 | 4 | $0 (2019) |
| Janssen Products, LP | $185.00 | 2 | $0 (2019) |
| ViiV Healthcare Company | $154.58 | 2 | $0 (2018) |
| Melinta Therapeutics, Inc. | $101.03 | 5 | $0 (2019) |
| Shionogi Inc | $76.19 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $68.60 | 5 | $0 (2022) |
| Seqirus USA Inc | $41.94 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $433.55 | 8 | Merck Sharp & Dohme LLC ($288.76) |
| 2021 | $16.22 | 1 | Ultragenyx Pharmaceutical Inc. ($16.22) |
| 2020 | $35.06 | 2 | Mylan Specialty L.P. ($22.50) |
| 2019 | $6,011 | 26 | AbbVie, Inc. ($5,477) |
| 2018 | $4,794 | 26 | Gilead Sciences, Inc. ($4,248) |
| 2017 | $4,019 | 15 | Gilead Sciences Inc ($3,916) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Gastroenterology | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Gastroenterology | ||||||
| 10/22/2022 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $144.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/22/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $76.19 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/18/2022 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $144.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/10/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Gastroenterology | ||||||
| 03/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Gastroenterology | ||||||
| 03/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Gastroenterology | ||||||
| 08/06/2021 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $16.22 | General |
| 09/15/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Respiratory and Allergy | ||||||
| 01/23/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Neuroscience | ||||||
| 12/09/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 11/18/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug), Vabomere | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: ANTIBIOTICS | ||||||
| 11/14/2019 | Janssen Products, LP | Symtuza (Drug) | Education | In-kind items and services | $60.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/22/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.21 | General |
| 10/05/2019 | Seqirus USA Inc | — | Education | In-kind items and services | $20.97 | General |
| 10/02/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $91.62 | General |
| 07/25/2019 | AbbVie, Inc. | Viekira Pak (Drug) | Consulting Fee | Cash or cash equivalent | $1,837.50 | General |
| Category: Virology | ||||||
| 07/25/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.84 | General |
| 05/28/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.10 | General |
| 04/18/2019 | AbbVie, Inc. | Mavyret (Drug) | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: Virology | ||||||
| 04/18/2019 | AbbVie, Inc. | Mavyret (Drug) | Travel and Lodging | In-kind items and services | $60.32 | General |
| Category: Virology | ||||||
| 04/18/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $42.00 | General |
| Category: Virology | ||||||
| 04/18/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: Virology | ||||||
| 04/11/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $46.67 | General |
| Category: ANTIBIOTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 5 | 93 | 157 | $17,307 | $8,947 |
Total Patients
93
Total Services
157
Medicare Billing
$8,947
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 59 | $9,057 | $4,737 | 52.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 20 | $4,140 | $2,108 | 50.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 34 | $3,536 | $1,952 | 55.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 20 | 29 | $319.00 | $86.46 | 27.1% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation | Office | 2020 | 11 | 15 | $255.00 | $63.69 | 25.0% |
About Dr. Gitanjali Pai, MD
Dr. Gitanjali Pai, MD is a Infectious Disease healthcare provider based in Wagoner, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1518197524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gitanjali Pai, MD has received a total of $15,308 in payments from pharmaceutical and medical device companies, with $433.55 received in 2022. These payments were reported across 78 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($9,418).
As a Medicare-enrolled provider, Pai has provided services to 93 Medicare beneficiaries, totaling 157 services with total Medicare billing of $8,947. Data is available for 1 year (2020–2020), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine
- Location Wagoner, OK
- Active Since 07/24/2009
- Last Updated 05/01/2025
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1518197524
Products in Payments
- Mavyret (Drug) $3,776
- Viekira Pak (Drug) $1,838
- VAXNEUVANCE (Biological) $288.76
- Symtuza (Drug) $185.00
- Biktarvy (Drug) $124.84
- JULUCA (Drug) $121.87
- DIFICID (Drug) $90.67
- Vemlidy (Drug) $82.02
- Fetroja (Drug) $76.19
- XIFAXAN (Drug) $68.60
- Orbactiv (Drug) $61.87
- Baxdela (Drug) $39.16
- TIVICAY (Drug) $32.71
- Yupelri (Drug) $22.50
- Fanapt (Drug) $13.89
- PREZCOBIX (Drug) $13.33
- EMGALITY (Drug) $12.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.